Allen AM, Kamath PS, Larson JJ, et al. Cardiovascular Risk in NAFLD- Not an Equal Opportunity: Implications for Women’s Health. AASLD 2017, abstract 55.
Neoadjuvant FOLFIRINOX versus gemcitabine-chemoradiotherapie bij (borderline) resectabel pancreascarcinoom
nov 2025 | Chirurgie, Maag-darm-leveroncologie